• LAST PRICE
    0.0964
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1000/ 52
  • Ask / Lots
    0.1080/ 50
  • Open / Previous Close
    0.0906 / 0.0964
  • Day Range
    Low 0.0900
    High 0.0979
  • 52 Week Range
    Low 0.0886
    High 2.4000
  • Volume
    2,736,311
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.0926
TimeVolumePBLA
09:32 ET23160.0906
09:39 ET1000.0913
09:42 ET498930.0943
09:44 ET12390.0942
09:46 ET299940.0915
09:48 ET150860.0942
09:50 ET190480.095
09:51 ET1727730.0949
09:53 ET39940.095
09:55 ET1000.0941
09:57 ET448510.0949
10:04 ET51000.0947
10:08 ET122400.095
10:09 ET98800.095
10:13 ET78000.095
10:15 ET4920.094996
10:18 ET17500.0949
10:20 ET103430.0949
10:22 ET1000.0926
10:26 ET4000.0929
10:31 ET2000.0949
10:36 ET2120.0938
10:38 ET200000.092601
10:42 ET1000.0928
10:49 ET1000.0928
10:51 ET314930.0949
10:54 ET1000.0949
10:56 ET242000.0949
10:58 ET3640.0949
11:00 ET1000.0949
11:02 ET245830.0918
11:03 ET2000.0935
11:05 ET1000.0935
11:07 ET1000.0935
11:09 ET11340.0935
11:12 ET2000.0935
11:14 ET116000.0935
11:16 ET1000.093
11:18 ET9000.0939
11:20 ET112800.0939
11:21 ET1000.0939
11:23 ET239000.0958
11:25 ET594440.0971
11:27 ET285080.097401
11:30 ET258160.0956
11:34 ET797970.0967
11:36 ET185980.097
11:38 ET1025870.0941
11:39 ET191000.095
11:41 ET116800.095
11:43 ET1408870.093
11:45 ET449720.093
11:48 ET49280.0931
11:52 ET901380.0945
11:54 ET13170.093999
11:56 ET108000.0944
11:57 ET262000.094
11:59 ET14000.094001
12:03 ET2000.093888
12:06 ET1000.0935
12:08 ET1000.0928
12:10 ET5000.094
12:12 ET1000.0916
12:14 ET10000.0916
12:15 ET3960.0941
12:19 ET18560.0941
12:21 ET464000.0943
12:28 ET46000.0943
12:30 ET20360.0944
12:33 ET1695280.094
12:35 ET6000.094301
12:42 ET121020.0935
12:44 ET58000.094
12:48 ET128590.0939
12:50 ET5000.0942
12:51 ET92810.0943
12:53 ET23000.0943
12:55 ET10000.093701
01:00 ET97360.0942
01:02 ET275170.0943
01:04 ET552430.0943
01:06 ET202500.0955
01:11 ET117020.0936
01:13 ET1000.0936
01:18 ET4000.0949
01:26 ET224000.093
01:27 ET1000.093
01:29 ET1000.093
01:31 ET1000.093
01:33 ET1000.093
01:36 ET1000.0931
01:38 ET1000.093
01:40 ET2000.094
01:42 ET1000.094
01:44 ET4000.093
01:45 ET1000.0921
01:47 ET1000.0921
01:49 ET4000.0922
01:51 ET1000.0921
01:54 ET400900.094
01:56 ET462690.0969
01:58 ET348650.0958
02:05 ET100000.095
02:18 ET4940.095
02:20 ET80000.095501
02:21 ET31990.095
02:23 ET5000.0959
02:25 ET11000.096
02:30 ET13770.0945
02:34 ET1000.093
02:36 ET1000.093
02:38 ET24440.093276
02:39 ET2000.093
02:41 ET1000.093
02:43 ET1000.093
02:45 ET1000.093
02:48 ET200130.093
02:50 ET2000.093
02:52 ET1000.093
02:54 ET1000.093
02:56 ET1000.093
02:57 ET2000.093
02:59 ET17880.093
03:01 ET8430.093
03:03 ET1000.093
03:06 ET477850.0933
03:08 ET1000.0933
03:10 ET2000.0933
03:12 ET12000.0933
03:14 ET1000.0933
03:15 ET210000.094
03:17 ET102000.0931
03:19 ET55000.095
03:21 ET1000.0931
03:24 ET1000.0932
03:26 ET121900.0961
03:28 ET34970.096
03:30 ET155890.0956
03:32 ET2000.095
03:33 ET304000.095437
03:35 ET4000.094
03:37 ET1000.094
03:39 ET2000.094
03:42 ET242980.0968
03:44 ET158400.0969
03:46 ET304140.0959
03:48 ET6000.095
03:51 ET59910.095
03:53 ET71000.0956
03:55 ET6000.0954
03:57 ET545860.0957
04:00 ET1008590.0964
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPBLA
Panbela Therapeutics Inc
2.9M
0.0x
---
United StatesPTEO
Proteo Inc
3.0M
0.0x
---
United StatesVLON
Vallon Pharmaceuticals Inc
2.8M
-0.2x
---
United StatesCNSP
CNS Pharmaceuticals Inc
3.2M
-6.8x
---
United StatesBZYR
Burzynski Research Institute Inc
3.2M
-3.6x
---
United StatesATRX
Adhera Therapeutics Inc
2.6M
-0.2x
---
As of 2022-12-09

Company Information

Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing disruptive therapeutics for the treatment of patients with cancer. Its primary focus is on the treatment of patients with pancreatic cancer. Its lead product candidate, SBP-101, is a polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma, ovarian cancer and other tumors. The Company is conducting Phase Ia/Ib study of the safety, tolerability and pharmacokinetics of SBP-101 when administered in combination with gemcitabine and nab-paclitaxel.

Contact Information

Headquarters
712 Vista Blvd # 305WACONIA, MN, United States 55387
Phone
952-479-1196
Fax
---

Executives

Chairman of the Board
Michael Cullen
President, Chief Executive Officer, Director
Jennifer Simpson
Lead Independent Vice Chairman of the Board
Jeffrey Mathiesen
Chief Financial Officer, Vice President - Finance, Treasurer, Company Secretary
Susan Horvath
Director
Suzanne Gagnon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.9M
Revenue (TTM)
$0.00
Shares Outstanding
31.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.04
EPS
$-2.26
Book Value
$0.76
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.